Onset 5

Fiasp and the ONSET5 Trial – What Novo Nordisk found in the CSII (pump) Clinical trial

Fiasp and the Onset 5 CSII Trial – What Novo Nordisk found

14/08/2018 admin 8

Around the time of launching Fiasp, Novo Nordisk embarked on a wider study of its use in Continuous Subcutaneous Insulin Infusion (CSII), or pumping as […]